iiinova — where your digital self keeps evolving

dolphin3study.bsky.social @dolphin3study.bsky.social · 23/10/2025

Jim Read presented updates on the #DOLPHIN3 study website, reminding all study sites and work pages leads that impactful communication starts with shared ownership, and that everyone has a role in generating engaging content. #AtTheEquatorUG @catrionawaitt.bsky.social @epibiostats-uct.bsky.social

011

dolphin3study.bsky.social @dolphin3study.bsky.social · 23/10/2025

The #DOLPHIN3 study Uganda site Principal Investigator Prof. @catrionawaitt.bsky.social taking participants through the importance of documentation, underlining how visual storytelling through videography strengthens research communication and knowledge sharing. #AtTheEquatorUG

000

dolphin3study.bsky.social @dolphin3study.bsky.social · 23/10/2025

Great session by Rufaro Mvududu on the #DOLPHIN3 study database, highlighting data flow, management processes, and the importance of standardization across study sites. She emphasized the importance of strengthening the study’s research outcomes. #AtTheEquatorUG @catrionawaitt.bsky.social

000

dolphin3study.bsky.social @dolphin3study.bsky.social · 23/10/2025

Insightful overview by Shadia Nakalema on the Infectious Diseases Institute's Manual of Procedure (MOP), outlining how structured procedures will support data quality, participant safety, and smooth trial operations across the Uganda study site. #DOLPHIN3 #AtTheEquatorUG @catrionawaitt.bsky.social

000

dolphin3study.bsky.social @dolphin3study.bsky.social · 23/10/2025

Siphesihle Sithole also emphasized standardized processes, staff roles, and data flow that underpin effective study implementation. #DOLPHIN3 #AtTheEquatorUG

000

dolphin3study.bsky.social @dolphin3study.bsky.social · 23/10/2025

The #DOLPHIN3 Study South Africa Coordinator, Siphesihle Mandisa Sithole, presenting an overview of the UCT Manual of Procedures (MOP) outlining key operational guidance to ensure consistency, quality, and coordination across the study site. #AtTheEquatorUG @epibiostats-uct.bsky.social

021

dolphin3study.bsky.social @dolphin3study.bsky.social · 23/10/2025

Insightful presentation by the #DOLPHIN3 study Principal Investigator Dr. Thoko Malaba on protocol amendments for Work Package 2 (Clinical Trial), outlining key updates that strengthen the study’s design, implementation, and participant safety. #AtTheEquatorUG @epibiostats-uct.bsky.social

011

dolphin3study.bsky.social @dolphin3study.bsky.social · 22/10/2025

Starting Day 2 on a high note! Prof. Catherine Orrell opened with an overview of Work Package 2 (Clinical Trial), sharing progress, challenges, and future directions for the #DOLPHIN3 study. #AtTheEquatorUG @epibiostats-uct.bsky.social @catrionawaitt.bsky.social @globalhealthedctp3.bsky.social

021

dolphin3study.bsky.social @dolphin3study.bsky.social · 22/10/2025

Strong focus on sustainability & skills development as Prof. David Burger presented an overview of Work Package 4: Capacity Building and Training, showcasing how #DOLPHIN3 is investing in mentorship, training, and strengthening local research expertise. #AtTheEquatorUG @catrionawaitt.bsky.social

010

dolphin3study.bsky.social @dolphin3study.bsky.social · 21/10/2025

Proud moments at the #DOLPHIN3 Consortium Meeting as PhD students Sihle Sithole & Shadia Nakalema presented their proposals, reinforcing the study’s commitment to capacity building & nurturing the next generation of scientists. #AtTheEquatorUG @epibiostats-uct.bsky.social @catrionawaitt.bsky.social

031

dolphin3study.bsky.social @dolphin3study.bsky.social · 21/10/2025

Group Work and discussion - Key Informant Interviews. Three groups (Uganda, South Africa & Europe) identifying key contextual issues, research topics &potential informants for LAI-ART scale up. #DOLPHIN3 #AtTheEquatorUG @epibiostats-uct.bsky.social @catrionawaitt.bsky.social @seniorcymo.bsky.social

041

dolphin3study.bsky.social @dolphin3study.bsky.social · 21/10/2025

"Work package 1 seeks to explore patient acceptability of long-acting injectable ART (LAI-ART) during breastfeeding and as a postpartum bridging strategy to enhance adherence."- Yussif Alhassan @lstmnews.bsky.social @epibiostats-uct.bsky.social @catrionawaitt.bsky.social #DOLPHIN3 #AtTheEquatorUG

041

dolphin3study.bsky.social @dolphin3study.bsky.social · 21/10/2025

Insightful first presentation by Yussif Alhassan, sharing Work Package 1 updates on protocol amendments, Uganda and South Africa FGDs, and stakeholder interviews, showcasing how community perspectives are shaping #DOLPHIN3. #AtTheEquatorUG @epibiostats-uct.bsky.social @catrionawaitt.bsky.social

031

dolphin3study.bsky.social @dolphin3study.bsky.social · 21/10/2025

The #DOLPHIN3 Consortium Meeting brings partners together & provides a platform to share progress, challenges, & lessons that shape our collective vision. Our goal is to ensure that every discovery moves us closer to safer, more effective treatments for mothers & babies @epibiostats-uct.bsky.social

021

dolphin3study.bsky.social @dolphin3study.bsky.social · 21/10/2025

Inspiring start to the #DOLPHIN3 Consortium Meeting at the @uct-fhs-research.bsky.social with opening remarks by Prof. Catherine Orrell, emphasizing partnership, innovation, and the shared goal of improving health outcomes for mothers and infants. #AtTheEquatorUG @catrionawaitt.bsky.social

020

dolphin3study.bsky.social @dolphin3study.bsky.social · 06/08/2025

The DOLPHIN3 study team from the University of Cape Town visited IDI to finalize the Manual of Procedures and participant identification strategies. #DOLPHIN3Study seeks to evaluate long-acting injectable antiretrovirals for postpartum mothers compared to the oral standard of care. #AtTheEquatorUG

010

dolphin3study.bsky.social @dolphin3study.bsky.social · 10/01/2025

The lack of access to LAI cabotegravir–rilpivirine for treatment and research in Africa impacts research and future implementation of LAI-ART. SDG 3.8 specifies access to safe, effective, quality, and affordable essential medicines and vaccines for all. #SDGs www.thelancet.com/journals/lan...

032